Covid-19 roundup: Eu­ro­pean vac­cines lob­by push­ing for li­a­bil­i­ty pro­tec­tion; VBI vac­cines to prep hu­man tri­als

With Covid-19 vac­cine pro­duc­tion mov­ing at a break­neck pace, some in the in­dus­try are push­ing for pro­tec­tions against po­ten­tial law­suits.

The Eu­ro­pean phar­ma in­dus­try’s vac­cines lob­by, Vac­cines Eu­rope, has been in dis­cus­sions with the EU to cre­ate pro­tec­tions for its mem­bers should any prob­lems arise with new coro­n­avirus vac­cines, ac­cord­ing to a re­port from the Fi­nan­cial Times. Giv­en that vac­cine re­search can gen­er­al­ly take years and the lead­ing de­vel­op­ers are al­ready in Phase III stud­ies, the lob­by is ad­vo­cat­ing ex­emp­tions from civ­il li­a­bil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER